J&J nabs its 1st Chinese device maker | Wall Street Beat

May 3, 2012 by MassDevice staff

Johnson & Johnson acquires its 1st Chinese medical device maker; Aethlon expects $1.4M in full-year revenues; Washington group pushes women's pelvic health; Invest in R&D, survey says; plus, GPO deals, a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

Health care giant Johnson & Johnson (NYSE:JNJ) made its 1st acquisition in China this week, picking up Guangzhou Bioseal Biotech for an undisclosed amount.

J&J has been doing business in China for more than 25 years, including last year's launch of a medical device and diagnostics innovation center there.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.